Rashonda Carlisle, MD
Advanced Heart Failure and Transplant Cardiology · San Antonio, TXNPI 1760979975
Payments from drug & device makers
What this record shows
This record is dominated by grants: $20,000 of the $30,353 with a category attached, or 65.9%. Abbott accounts for 69.8% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2024 at $24,002 and has fallen 93.6% since, to $1,538 in 2025.
Across 114 payments — averaging $266.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$21K
- Abiomed$3K
- Cvrx, Inc.$2K
- Medtronic$951
- Shockwave Medical, Inc$880
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$526
- plus $2K from 15 others
What the payments were for
- Grants$20,00066%
- Travel & lodging$3,47211%
- Food & beverage$6,12520%
- Education$7572%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 21 | $21,188 |
| Abiomed | 20 | $2,762 |
| Cvrx, Inc. | 18 | $2,357 |
| Medtronic | 7 | $951 |
| Shockwave Medical, Inc | 7 | $880 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $526 |
| Boston Scientific | 5 | $523 |
| AstraZeneca | 5 | $319 |
| Biosense Webster, Inc. | 2 | $175 |
| Penumbra, Inc. | 2 | $149 |
| Cardiva Medical, Inc. | 4 | $114 |
| E.r. Squibb & Sons, L.L.C. | 1 | $106 |
| Boehringer Ingelheim | 3 | $70 |
| Heartflow, Inc. | 2 | $41 |
| Merck | 2 | $36 |
| Johnson & Johnson | 1 | $34 |
| Pfizer | 2 | $34 |
| United Therapeutics Corporation | 1 | $27 |
| Terumo Medical Corporation | 1 | $22 |
| Scpharmaceuticals Inc. | 1 | $20 |
| Tactile Systems Technology Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$2,082
- Barostim Neo System$1,752
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$787
- ENSITE$599
- AMPLATZER$168
- LifeVest$153
- Carto 3$142
- Indigo System$130
- SYNERGY$111
- GENERAL - THERAPIES$109
- CAMZYOS$106
- BRILINTA$104
- XACT$101
How this compares
$30,353 in reported general payments places this provider in the 65th percentile of 75 advanced heart failure and transplant cardiology providers in Texas.
See all advanced heart failure and transplant cardiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in San Antonio
- Allen AndersonSan Antonio$413K
- Alejandro Folch SandovalSan Antonio$44K
- Sachin GuptaSan Antonio$25K
- Mahek ShahSan Antonio$11K
- Tamer AmerSan Antonio$11K
- Mohammed AslamSan Antonio$8K
- Robert GottliebDallas$717K
- Albert HicksTemple$613K
- Martin BerkDallas$379K
- Aasim AfzalPlano$336K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.